Plasma connective tissue growth factor is an independent predictor of end-stage renal disease and mortality in type 1 diabetic nephropathy

Diabetes Care

Volumn 31, Issue 6, 2008, Pages 1177-1182

  Nguyen, Tri Q ^a   Tarnow, Lise ^b   Jorsal, Anders ^b   Oliver, Noelynn ^c   Roestenberg, Peggy ^a   Ito, Yasuhiko ^d   Parving, Hans Henrik ^e,f   Rossing, Peter ^b   Van Nieuwenhoven, Frans A ^a   Goldschmeding, Roel ^a,g  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b STENO DIABETES CENTER   (Denmark)

^c FIBROGEN INC   (United States)

^d NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e Rigshospitalet   (Denmark)

^f AARHUS UNIVERSITY   (Denmark)

^g Department of Pathology ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; BIOLOGICAL MARKER; IMMEDIATE EARLY PROTEIN; SIGNAL PEPTIDE;

ADULT; ALBUMINURIA; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; RISK FACTOR; SENSITIVITY AND SPECIFICITY; BLOOD; CHRONIC KIDNEY FAILURE; DIABETIC RETINOPATHY; KIDNEY FUNCTION TEST; MIDDLE AGED; PREDICTION AND FORECASTING; PROPORTIONAL HAZARDS MODEL;

ADULT; BIOLOGICAL MARKERS; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 48649102468     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc07-2469     Document Type: Article

References (30)

1. Locatelli F, Pozzoni P, Del Vecchio L: Renal replacement therapy in patients with diabetes and end-stage renal disease. J Am Soc Nephrol 15 (Suppl 1):S25-S29, 2004
2. Bradham DM, Igarashi A, Potter RL, Grotendorst GR: Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 114: 1285-1294, 1991
3. Leask A, Abraham DJ: TGF-beta signaling and the fibrotic response. FASEB J 18:816-827, 2004
4. Perbal B: CCN proteins: multifunctional signalling regulators. Lancet 363:62-64, 2004
5. Murphy M, Godson C, Cannon S, Kato S, Mackenzie HS, Martin F, Brady HR: Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesan- gial cells. J Biol Chem 274:5830-5834, 1999
6. Riser BL, deNichilo M, Cortes P, Baker C, Grondin JM, Yee J, Narins RG: Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. J Am Soc Nephrol 11:25-38, 2000
7. Blom IE, van Dijk AJ, Wieten L, Duran K, Ito Y, Kleij L, deNichilo M, Rabelink TJ, Weening JJ, Aten J, Goldschmeding R: In vitro evidence for differential involvement of CTGF, TGFβ, and PDGF-BB in mesangial response to injury. Nephrol Dial Transplant 16:1139-1148, 2001
8. Burns WC, Twigg SM, Forbes JM, Pete J, Tikellis C, Thallas-Bonke V, Thomas MC, Cooper ME, Kantharidis P: Connective tissue growth factor plays an important role in advanced glycation end product- induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease. JAm Soc Nephrol 17:2484-2494, 2006
9. Ito Y, Aten J, Bende RJ, Oemar BS, Ra- belink TJ, Weening JJ, Goldschmeding R: Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 53:853-861, 1998
10. Roestenberg P, van Nieuwenhoven FA, Joles JA, Trischberger C, Martens PP, Oliver N, AtenJ, Hoppener JW, Goldschmeding R: Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice. Am J Physiol 290:F1344-F1354, 2006
11. Adler SG, Kang SW, Feld S, Cha DR, Barba L, Striker L, Striker G, Riser BL, Lapage J, Nast CC: Glomerular mRNAs in human type 1 diabetes: biochemical evidence for microalbuminuria as a manifestation of diabetic nephropathy. Kidney Int 60:2330-2336, 2001
12. Wahab NA, Schaefer L, Weston BS, Yiannikouris O, Wright A, Babelova A, Schaefer R, Mason RM: Glomerular expression of thrombospondin-1, transforming growth factor β and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli. Diabetologia 48:2650-2660, 2005
13. Guha M, Xu ZG, Tung D, Lanting L, Natarajan R: Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes. FASEB J 21:3355-3368, 2007
14. Flyvbjerg A, Khatir D, Jensen LJN, Lomongsod E, Liu DY, Rasch R, Usinger WR: Long-term renal effects of a neutralizing connective tissue growth factor (CTGF)-antibody in obese type 2 diabetic mice (Abstract). J Am Soc Nephrol 15:261A, 2004
15. Goldschmeding R, Roestenberg P, Joles JA, Lyons KM, van Nieuwenhoven FA: Diabetic GBM thickening is CTGF-de- pendent and involves reduced MMP-activity (Abstract). J Am Soc Nephrol 17:128A, 2006
16. Riser BL, Cortes P, deNichilo M, Desh- mukh PV, Chahal PS, Mohammed AK, Yee J, Kahkonen D: Urinary CCN2 (CTGF) as a possible predictor of diabetic nephropathy: preliminary report. Kidney Int 64:451-458, 2003
17. Gilbert RE, Akdeniz A, Weitz S, Usinger WR, Molineaux C, Jones SE, Langham RG, Jerums G: Urinary connective tissue growth factor excretion in patients with type 1 diabetes and nephropathy. Diabetes Care 26:2632-2636, 2003
18. Roestenberg P, van Nieuwenhoven FA, Wieten L, Boer P, Diekman T, Tiller AM, Wiersinga WM, Oliver N, Usinger W, Weitz S, Schlingemann RO, Goldschmeding R: Connective tissue growth factor is increased in plasma of type 1 diabetic patients with nephropathy. Diabetes Care 27:1164-1170, 2004
19. Andersen S, van Nieuwenhoven FA, Tar- now L, Rossing P, Rossing K, Wieten L, Goldschmeding R, Parving HH: Reduction of urinary connective tissue growth factor by losartan in type 1 patients with diabetic nephropathy. Kidney Int 67:2325-2329, 2005
20. Nguyen TQ, Tarnow L, Andersen S, Hovind P, Parving HH, Goldschmeding R, van Nieuwenhoven FA: Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy. Diabetes Care 29:83-88, 2006
21. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, Poirier O, Da- nilov S, Parving HH: Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 44:489-494, 1995
22. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, Poirier O, Danilov S, Boelskifte S, Parving HH: Insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy. Diabetologia 38:798 -803, 1995
23. Parving HH, Mauer M, Ritz E: Diabetic Nephropathy. In Brenner & Rector's The Kidney. 7th ed. Brenner BM, Ed. Philadelphia, Saunders, p. 1777-1818, 2004
24. Brochner-Mortensen J, Rodbro P: Selection of routine method for determination of glomerular filtration rate in adult patients. Scand J Clin Lab Invest 36:35-43, 1976
25. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461-470, 1999
26. Keane WF, Brenner BM, de ZD, Grunfeld JP, McGill J, Mitch WE, Ribeiro AB, Shahinfar S, Simpson RL, Snapinn SM, Toto R: The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study. Kidney Int 63:1499-1507, 2003
27. Hovind P, Tarnow L, Rossing P, Carstensen B, Parving HH: Improved survival in patients obtaining remission of nephrotic range albuminuria in diabetic nephropathy. Kidney Int 66:1180-1186, 2004
28. Hovind P, Rossing P, Tarnow L, Smidt UM, Parving HH: Progression of diabetic nephropathy. Kidney Int 59:702-709, 2001
29. Jacobsen P, Rossing K, Tarnow L, Rossing P, Mallet C, Poirier O, Cambien F, Parving HH: Progression of diabetic nephropathy in normotensive type 1 diabetic patients. Kidney Int Suppl 71:S101-S105, 1999
30. Shi Y, Tu Z, Wang W, Li Q, Ye F, Wang J, Qiu J, Zhang L, Bu H, Li Y: Homologous peptide of connective tissue growth factor ameliorates epithelial to mesenchymal transition of tubular epithelial cells. Cytokine 36:35-44, 2006